Secukinumab improves mild-to-moderate psoriasis: A randomized, placebo-controlled exploratory clinical trial

Affiliations

• ¹ Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York; Department of Dermatology, University of California, Davis, Sacramento, California; Dermatology Section, Veterans Affairs Northern California Health Care System, Mather, California. Electronic address: derkim@ucdavis.edu.
• ² Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York.
• ³ Department of Dermatology, University of California, Davis, Sacramento, California.
• ⁴ Research Bioinformatics, Center for Clinical and Translational Science, The Rockefeller University, New York, New York.
• ⁵ Laboratory of Single-cell Genomics and Population Dynamics, The Rockefeller University, New York, New York.
• ⁶ Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York. Electronic address: jgk@rockefeller.edu.